Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level

9 de julho de 2026 atualizado por: Ankara Yildirim Beyazıt University
This randomized controlled experimental study was conducted to evaluate the effects of virtual reality glasses used during hemodialysis on patients' vital signs and anxiety levels. A total of 56 adult patients receiving hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital were randomly assigned to either an experimental group or a control group. Patients in the experimental group watched a 4K virtual reality nature video with relaxing background music during hemodialysis, while the control group received standard hemodialysis care. Vital signs, pain, anxiety, and satisfaction were assessed to evaluate the effectiveness of the virtual reality intervention.

Visão geral do estudo

Descrição detalhada

The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.

The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).

Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.

Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.

Tipo de estudo

Intervencional

Inscrição (Real)

56

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Ankara, Turquia (Türkiye), 06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Receiving hemodialysis treatment for the first time.
  • Age ≥18 years.
  • No visual, hearing, or cognitive impairment.
  • Able to communicate effectively.
  • Clinically stable.
  • No diagnosed psychiatric disorder or use of psychiatric medication.
  • No history of seizures.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Previous hemodialysis treatment.
  • Age <18 years.
  • Visual, hearing, or cognitive impairment.
  • History of kidney transplantation.
  • Communication difficulties.
  • Diagnosed psychiatric disorder or use of psychiatric medication.
  • History of seizures.
  • Declined to participate in the study.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes. The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
Comparador Ativo: Control Group
Participants received standard hemodialysis care without any additional intervention.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Systolic Blood Pressure
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in systolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Diastolic Blood Pressure
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in diastolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Heart Rate
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in heart rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Respiratory Rate
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in respiratory rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Peripheral Oxygen Saturation (SpO₂)
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Body Temperature
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in body temperature measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
State Anxiety Level After Hemodialysis
Prazo: Immediately after completion of the hemodialysis session.
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Pain Score
Prazo: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain. Pain was assessed before and immediately after completion of the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Participant Satisfaction Score
Prazo: Immediately after completion of the hemodialysis session.
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied. Higher scores indicate greater participant satisfaction. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Diretor de estudo: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

3 de maio de 2023

Conclusão Primária (Real)

27 de maio de 2024

Conclusão do estudo (Real)

27 de maio de 2024

Datas de inscrição no estudo

Enviado pela primeira vez

28 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

9 de julho de 2026

Primeira postagem (Real)

15 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

15 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

9 de julho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Descrição do plano IPD

The decision regarding sharing of individual participant data has not yet been finalized. Any future data sharing will be considered in accordance with institutional policies, ethical requirements, and applicable regulations.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever